Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S P Lam

Showing results (151-160 of 843) with videos related to

Pageof 85
Sort By:
ESC Heart Failure|October 25, 2016
Rationale and design of a pilot randomized controlled trial to assess the role of intravenous ferric carboxymaltose in Asian patients with heart failure (PRACTICE-ASIA-HF)Tee Joo Yeo, Poh Shuan Daniel Yeo, Farid Abdul Hadi, et al.
European Journal of Heart Failure|March 3, 2020
Interactions between left ventricular ejection fraction, sex and effect of neurohumoral modulators in heart failurePooja Dewan, Alice Jackson, Carolyn S P Lam, et al.
BMC Public Health|May 30, 2023
Identification of urgent gaps in public and policymaker knowledge of heart failure: Results of a global surveyCarolyn S P Lam, Ed Harding, Marc Bains, et al.
Sleep Medicine|December 1, 2009
Validation of a new REM sleep behavior disorder questionnaire (RBDQ-HK)S X Li, Y K Wing, S P Lam, et al.
European Journal of Heart Failure|March 28, 2020
Evaluation of high-sensitivity C-reactive protein and uric acid in vericiguat-treated patients with heart failure with reduced ejection fractionFrank Kramer, Sebastian Voss, Lothar Roessig, et al.
JACC. Heart Failure|June 4, 2016
Prognosis of Adults With Borderline Left Ventricular Ejection FractionConnie W Tsao, Asya Lyass, Martin G Larson, et al.
Diabetes, Obesity & Metabolism|October 7, 2020
Design and baseline characteristics of the AMPLITUDE-O cardiovascular outcomes trial of efpeglenatide, a weekly glucagon-like peptide-1 receptor agonistHertzel C Gerstein, Kelley Branch, Laura Heenan, et al.
European Journal of Applied Physiology|May 16, 2016
Impact of aortic root size on left ventricular afterload and stroke volumeAnders Sahlén, Nadira Hamid, Mohammed Rizwan Amanullah, et al.
Journal of Cardiac Failure|January 20, 2022
Relationship Between Soluble Transferrin Receptor and Clinical Outcomes in Patients With Heart Failure According to Ejection Fraction Phenotype: The New Zealand PEOPLE StudySarah Fitzsimons, Katrina K Poppe, Yeunhyang Choi, et al.
Clinical Cardiology|March 11, 2021
Contemporary economic burden in a real-world heart failure population with Commercial and Medicare supplemental plansCarolyn S P Lam, Robert Wood, Muthiah Vaduganathan, et al.
Pageof 85

Showing results (151-160 of 843) with videos related to

Sort By:
Pageof 85
ESC Heart Failure|October 25, 2016
Rationale and design of a pilot randomized controlled trial to assess the role of intravenous ferric carboxymaltose in Asian patients with heart failure (PRACTICE-ASIA-HF)Tee Joo Yeo, Poh Shuan Daniel Yeo, Farid Abdul Hadi, et al.
European Journal of Heart Failure|March 3, 2020
Interactions between left ventricular ejection fraction, sex and effect of neurohumoral modulators in heart failurePooja Dewan, Alice Jackson, Carolyn S P Lam, et al.
BMC Public Health|May 30, 2023
Identification of urgent gaps in public and policymaker knowledge of heart failure: Results of a global surveyCarolyn S P Lam, Ed Harding, Marc Bains, et al.
Sleep Medicine|December 1, 2009
Validation of a new REM sleep behavior disorder questionnaire (RBDQ-HK)S X Li, Y K Wing, S P Lam, et al.
European Journal of Heart Failure|March 28, 2020
Evaluation of high-sensitivity C-reactive protein and uric acid in vericiguat-treated patients with heart failure with reduced ejection fractionFrank Kramer, Sebastian Voss, Lothar Roessig, et al.
JACC. Heart Failure|June 4, 2016
Prognosis of Adults With Borderline Left Ventricular Ejection FractionConnie W Tsao, Asya Lyass, Martin G Larson, et al.
Diabetes, Obesity & Metabolism|October 7, 2020
Design and baseline characteristics of the AMPLITUDE-O cardiovascular outcomes trial of efpeglenatide, a weekly glucagon-like peptide-1 receptor agonistHertzel C Gerstein, Kelley Branch, Laura Heenan, et al.
European Journal of Applied Physiology|May 16, 2016
Impact of aortic root size on left ventricular afterload and stroke volumeAnders Sahlén, Nadira Hamid, Mohammed Rizwan Amanullah, et al.
Journal of Cardiac Failure|January 20, 2022
Relationship Between Soluble Transferrin Receptor and Clinical Outcomes in Patients With Heart Failure According to Ejection Fraction Phenotype: The New Zealand PEOPLE StudySarah Fitzsimons, Katrina K Poppe, Yeunhyang Choi, et al.
Clinical Cardiology|March 11, 2021
Contemporary economic burden in a real-world heart failure population with Commercial and Medicare supplemental plansCarolyn S P Lam, Robert Wood, Muthiah Vaduganathan, et al.
Pageof 85